Northwell Ventures

Northwell Ventures is the corporate venture capital arm of Northwell Health — New York State's largest private employer and integrated healthcare delivery network, comprising 21-plus hospitals and more than 850 ambulatory sites — operating under Northwell Holdings, the system's for-profit commercialization subsidiary established in 2015. The unit is led by President and CEO Richard Mulry, a 25-plus-year veteran of healthcare administration and operations. Its mandate is to improve the future of healthcare by investing in companies that drive higher-quality outcomes, increase operating efficiency, lower the total cost of care, and improve the patient experience. Northwell Ventures leads rounds and is active from seed through Series B, and has made approximately 40 investments to date. The firm is highly selective: it receives more than 2,000 external startup inquiries per year and invests in roughly one in every 300 companies reviewed. Activity is organized across three pillars — venture investment, joint ventures and co-creation, and data strategy and commercialization. Flagship initiatives include Ascertain, a joint healthcare-AI company creation platform launched with Aegis Ventures in 2022 and 2023 and capitalized with $100 million to systematically launch AI companies for maternal and fetal health and chronic disease detection; and Clarapath, a 2021 spin-out automating pathology labs with AI-powered robotics that raised a $36 million Series B-1 in 2024 led by Northwell Ventures with Mayo Clinic and Ochsner Ventures, bringing total funding to $75 million. Other portfolio names include Optain, Hume, Prolucent, Playback Health, and Memora Health. Northwell's commercial and clinical scale gives its venture arm privileged access to real-world patient workflows and health-system data — a structural advantage that few hospital-affiliated CVCs can match.